Den 2. september 2008 er indre værdi på selskabets aktie beregnet til 91,63.

Correction to Consolidated Interim Report 1 January – 30 June 202614 August 2026Announcement no. 10 The previous announcement with the half year report was missing the report. The announcement is...

Consolidated Interim Report 1 January – 30 June 202614 August 2025Announcement no. 9 On 14 August 2026, the Board of Directors and the Executive Board of Pharma Equity Group A/S ("PEG", "The Company"...